Pheast
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
168 Waverley St Apt 9, Palo Alto, Califo...Website
www.pheast.comRevenue
$5.1 MillionIndustry
About Pheast
Is Pheast your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Pheast
Check if Pheast has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Pheast recently announced quarterly report
Click to see if Pheast had a recent Job posting/layoffs
Check out if Pheast is spiking on competitors!
Funding: Get notified immidiatlly once Pheast has new funding data
Pheast, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Pheast launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Pheast as Masked Content
Find 3 more new buyers
Compare Similar Companies to Pheast
Compare insights from companies similar to Pheast, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pheast
Company Profile Activity
Activity Insights
Pheast is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pheast is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pheast.
Pheast financials insights
Gather financial insights about Pheast, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$76M
Pheast Tech Stack
A closer look at the technologies used by Pheast
Most Recent Scoops
Pheast News & Media
Pheast Therapeutics Reports Initial Phase 1a Data Showing Early Clinical Activity and Target Engagement for PHST001 at AACR 2026
Initial clinical data highlight a differentiated safety and pharmacologic profile for PHST001, including target engagement, innate immune activation, and early signals of clinical activityPheast Therapeutics Advances PHST001, an IgG4 Anti-CD24 Monoclonal Antibody, into Phase 1b Combination Cohorts
First patient dosed in Phase 1b portion of ongoing Phase 1 study evaluating PHST001 in combination with chemotherapyPheast Therapeutics Receives FDA Fast Track Designation for PHST001 for the Treatment of Ovarian Cancer
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- #cancer--Pheast Therapeutics Receives FDA Fast Track Designation for PHST001 for the Treatment of Ovarian CancerPheast Therapeutics Announces First Patient Treated in Phase 1 Clinical Trial of PHST001 for Patients with Advanced Solid Tumors
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- #cancer--Pheast Therapeutics Announces First Patient Treated in Phase 1 Clinical Trial of PHST001 for Patients with Advanced Solid Tumors
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Pheast
Founded in 2020 and headquartered in Palo Alto, California, Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.... Read More